Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP278930.RASvT1e_2jRMexVkDFffWdixEft30irv0GyLU6HSy3Hj0130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278930.RASvT1e_2jRMexVkDFffWdixEft30irv0GyLU6HSy3Hj0130_provenance.
• NP279549.RAYfuxLvyDvAVCqWA5PUHChwWo-GkFE1Fx3pq__LLjGeQ130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279549.RAYfuxLvyDvAVCqWA5PUHChwWo-GkFE1Fx3pq__LLjGeQ130_provenance.
• NP279320.RAADFNeRvnQIq3zjUSHXrVqNnlb-cTROQjAAXzOeBBIQE130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279320.RAADFNeRvnQIq3zjUSHXrVqNnlb-cTROQjAAXzOeBBIQE130_provenance.
• NP278700.RAnX23CenbYxlX675W-8AiVWOqec8JSZb5ellbL0LzlAg130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278700.RAnX23CenbYxlX675W-8AiVWOqec8JSZb5ellbL0LzlAg130_provenance.
• NP1399003.RAdI-NZ9qzo29ZqlW8CQTse28uPeVGr4H3YYnEzyzX05Y130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1399003.RAdI-NZ9qzo29ZqlW8CQTse28uPeVGr4H3YYnEzyzX05Y130_provenance.
• NP853827.RAEtmDpwyyL8eI2C4UChBq30ufMxgPBJO3q7eYj73eyK4130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853827.RAEtmDpwyyL8eI2C4UChBq30ufMxgPBJO3q7eYj73eyK4130_provenance.
• NP1398999.RAhVunyMyj3csrxhxBOxTjjSmNrAFNKVq6ozK0wCE1RMY130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1398999.RAhVunyMyj3csrxhxBOxTjjSmNrAFNKVq6ozK0wCE1RMY130_provenance.
• NP1399007.RAj9Xcb2FUavbJa6HdgB1zs1P_BalU_vCElYs-TRDC1Ww130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1399007.RAj9Xcb2FUavbJa6HdgB1zs1P_BalU_vCElYs-TRDC1Ww130_provenance.
• NP279007.RAxaf1mExHpL71DfAAajcHOycvS6QGCpUE2JamffNmoGo130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279007.RAxaf1mExHpL71DfAAajcHOycvS6QGCpUE2JamffNmoGo130_provenance.
• NP279240.RAETWw4xKboKgNIYJfTEtobb8y_K6LTYKfJSi21cdRQxY130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279240.RAETWw4xKboKgNIYJfTEtobb8y_K6LTYKfJSi21cdRQxY130_provenance.
• NP1399000.RAKIhwOT_r1XtJvthP7LorYMEADwxkdQ-1RB2xqpG2xis130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1399000.RAKIhwOT_r1XtJvthP7LorYMEADwxkdQ-1RB2xqpG2xis130_provenance.
• NP1399002.RAHZJJFj5s2h5s4clBSdb0bOU2BLZSGvsHe8K0SB7akFE130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1399002.RAHZJJFj5s2h5s4clBSdb0bOU2BLZSGvsHe8K0SB7akFE130_provenance.
• NP1399004.RA7ux9SDzl9RX2UEeHWPtv99dFvMakUmpQBGeS5mRB5T4130_assertion description "[Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1399004.RA7ux9SDzl9RX2UEeHWPtv99dFvMakUmpQBGeS5mRB5T4130_provenance.